- Home
- ALEC vs ACR Comparison
ALEC vs ACR Comparison
Compare ALEC & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | ACR |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | United States | United States |
| Employees | N/A | 4 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.8M | 146.1M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALEC | ACR |
|---|---|---|
| Price | $1.48 | $17.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $4.83 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 772.7K | 22.3K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $29.87 | N/A |
| P/E Ratio | ★ N/A | $19.59 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $15.61 |
| 52 Week High | $3.40 | $24.61 |
Technical Indicators
Market Signals| Indicator | ALEC | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 49.83 |
| Support Level | $1.37 | $17.34 |
| Resistance Level | $1.60 | $18.30 |
| Average True Range (ATR) | 0.12 | 0.47 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 20.83 | 69.01 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.